A Study of LY2784544 in Participants With Myeloproliferative Neoplasms
Clinical trial NCT01594723 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01594723
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-22
- Primary completion
- 2015-03-20
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.